Azuma YT - Search Results

1

Interleukin-19 Abrogates Experimental Autoimmune Encephalomyelitis by Attenuating Antigen-Presenting Cell Activation.

Horiuchi H, Parajuli B, Komiya H, Ogawa Y, Jin S, Takahashi K, Azuma YT, Tanaka F, Suzumura A, Takeuchi H. Horiuchi H, et al. Among authors: azuma yt. Front Immunol. 2021 Mar 11;12:615898. doi: 10.3389/fimmu.2021.615898. eCollection 2021. Front Immunol. 2021. PMID: 33776998 Free PMC article.

2

Interleukin-19 protects mice from innate-mediated colonic inflammation.

Azuma YT, Matsuo Y, Kuwamura M, Yancopoulos GD, Valenzuela DM, Murphy AJ, Nakajima H, Karow M, Takeuchi T. Azuma YT, et al. Inflamm Bowel Dis. 2010 Jun;16(6):1017-28. doi: 10.1002/ibd.21151. Inflamm Bowel Dis. 2010. PMID: 19834971

3

Interleukin-19 acts as a negative autocrine regulator of activated microglia.

Horiuchi H, Parajuli B, Wang Y, Azuma YT, Mizuno T, Takeuchi H, Suzumura A. Horiuchi H, et al. Among authors: azuma yt. PLoS One. 2015 Mar 20;10(3):e0118640. doi: 10.1371/journal.pone.0118640. eCollection 2015. PLoS One. 2015. PMID: 25794104 Free PMC article.

4

[Recent progress in the pathophysiological role of interleukin-19].

Fujimoto Y, Azuma YT. Fujimoto Y, et al. Among authors: azuma yt. Nihon Yakurigaku Zasshi. 2019;154(2):66-71. doi: 10.1254/fpj.154.66. Nihon Yakurigaku Zasshi. 2019. PMID: 31406045 Review. Japanese.

5

Interleukin-19 enhances cytokine production induced by lipopolysaccharide and inhibits cytokine production induced by polyI:C in BALB/c mice.

Azuma YT, Nishiyama K. Azuma YT, et al. J Vet Med Sci. 2020 Jul 10;82(7):891-896. doi: 10.1292/jvms.20-0137. Epub 2020 May 7. J Vet Med Sci. 2020. PMID: 32378521 Free PMC article.

6

Ablation of interleukin-19 improves motor function in a mouse model of amyotrophic lateral sclerosis.

Komiya H, Takeuchi H, Ogawa Y, Suzuki K, Ogasawara A, Takahashi K, Azuma YT, Doi H, Tanaka F. Komiya H, et al. Among authors: azuma yt. Mol Brain. 2021 Apr 30;14(1):74. doi: 10.1186/s13041-021-00785-8. Mol Brain. 2021. PMID: 33931083 Free PMC article.

7

Interleukin-19 is a negative regulator of innate immunity and critical for colonic protection.

Azuma YT, Matsuo Y, Nakajima H, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, Takeuchi T. Azuma YT, et al. J Pharmacol Sci. 2011;115(2):105-11. doi: 10.1254/jphs.10r02cr. Epub 2010 Dec 9. J Pharmacol Sci. 2011. PMID: 21157117 Free article. Review.

8

Adenosine and ATP affect LPS-induced cytokine production in canine macrophage cell line DH82 cells.

Fujimoto Y, Nakatani N, Kubo T, Semi Y, Yoshida N, Nakajima H, Iseri T, Azuma YT, Takeuchi T. Fujimoto Y, et al. Among authors: azuma yt. J Vet Med Sci. 2012 Jan;74(1):27-34. doi: 10.1292/jvms.11-0228. Epub 2011 Aug 29. J Vet Med Sci. 2012. PMID: 21873810 Free article.

9

IL-19 as a potential therapeutic in autoimmune and inflammatory diseases.

Azuma YT, Nakajima H, Takeuchi T. Azuma YT, et al. Curr Pharm Des. 2011 Nov;17(34):3776-80. doi: 10.2174/138161211798357845. Curr Pharm Des. 2011. PMID: 22103848 Review.

10

Interleukin 19 reduces inflammation in chemically induced experimental colitis.

Matsuo Y, Azuma YT, Kuwamura M, Kuramoto N, Nishiyama K, Yoshida N, Ikeda Y, Fujimoto Y, Nakajima H, Takeuchi T. Matsuo Y, et al. Among authors: azuma yt. Int Immunopharmacol. 2015 Dec;29(2):468-475. doi: 10.1016/j.intimp.2015.10.011. Epub 2015 Oct 23. Int Immunopharmacol. 2015. PMID: 26476684

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters